<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Structural alterations of the c-myc oncogene in human Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and mouse <z:hpo ids='HP_0011857'>plasmacytoma</z:hpo> suggest that this oncogene is involved in several B cell <z:hpo ids='HP_0002664'>neoplasms</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The possibility of c-myc alterations in human <z:mp ids='MP_0009440'>myeloma</z:mp> has not been explored, probably because the low proliferative activity characteristic of this <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> impairs the propagation of representative cell lines for the performance of adequate cytogenetic studies </plain></SENT>
<SENT sid="2" pm="."><plain>This report describes alterations in the c-myc locus with concomitant elevated expression of <z:chebi fb="2" ids="33699">mRNA</z:chebi> in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells of two of 37 patients with <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>In one case, somatic cell hybrid studies revealed that the cloned rearranged DNA was entirely derived from chromosome 8, thus indicating a novel mechanism of c-myc activation different from that in Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Seven other patients exhibited five- to 12-fold overexpression of c-myc <z:chebi fb="40" ids="33697">RNA</z:chebi> when compared with <z:mpath ids='MPATH_458'>normal</z:mpath> marrow cells </plain></SENT>
<SENT sid="5" pm="."><plain>Elevated <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression in about one fourth of our patients suggests that the c-myc oncogene has a pathogenetic role in the evolution of <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> </plain></SENT>
</text></document>